Cargando…
VEGFR Inhibitors for Uterine Metastatic Perivascular Epithelioid Tumors (PEComa) Resistant to mTOR Inhibitors. A Case Report and Review of Literature
Uterine perivascular epithelioid cell tumors (PEComas) are rare neoplasms. PI3K/AKT/mTOR pathway upregulation is critical for their pathogenesis and is often associated with TSC1/TSC2 inactivation. Although first line mTOR inhibitors are an effective treatment, metastatic PEComas eventually progress...
Autores principales: | Liapi, Aikaterini, Mathevet, Patrice, Herrera, Fernanda G., Hastir, Delfyne, Sarivalasis, Apostolos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8032946/ https://www.ncbi.nlm.nih.gov/pubmed/33842348 http://dx.doi.org/10.3389/fonc.2021.641376 |
Ejemplares similares
-
So-Called Serous Carcinoma of the Uterine Cervix with BRCA2 Mutation: Case Report and Review of the Literature
por: Herrera Gómez, Ruth Gabriela, et al.
Publicado: (2021) -
Uterine perivascular epithelioid tumors (PEComas) with lung metastasis showed good responses to mTOR and VEGFR inhibitors: A case report
por: Sui, Chengxu, et al.
Publicado: (2022) -
Perivascular Epithelioid Cell Tumors (PEComas) of the Orbit
por: Paliogiannis, Panagiotis, et al.
Publicado: (2017) -
Perivascular epithelioid cell tumor (PEComa) of the pterygopalatine fossa
por: Dougherty, Michael I., et al.
Publicado: (2020) -
Malignant perivascular epithelioid cell tumor (PEComa) of the uterus
por: Cao, Bo, et al.
Publicado: (2022)